stocksSTAR
STAR

Strides Pharma Science Ltd.

1,126.80+0.4 (+0.04%)
3 Jul, 3:30 PM

Annual Reports and Financial Documents

Strides Pharma Science Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
2014201520162017201820192020202120222023202420252026
Annual ReportsFY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Quarterly Results
Conference Calls
Presentations

Corporate Announcements and Regulatory Filings

Strides Pharma Science Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  • Restructuring3 Jul 2026
    Announcement under Regulation 30 (LODR)-Restructuring
    Update on Completion of Transaction relating to Pivot Path.
  • Restructuring27 Jun 2026
    Announcement under Regulation 30 (LODR)-Restructuring
    Strides Partners with Ascent Capital to Unlock Value in Pivot Path
  • Press Release / Media Release27 Jun 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Strides Partners with Ascent Capital to Unlock Value in Pivot Path
  • Closure of Trading Window24 Jun 2026
    Closure of Trading Window
    Intimation regarding closure of Trading Window for the quarter ended June 30, 2026.
  • Analyst / Investor Meet8 Jun 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Intimation of Schedule of Analyst/ Institutional Investors Meet
  • General1 Jun 2026
    Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - Reminder To Shareholders Regarding Unclaimed Dividends And Transfer To IEPF
    Reminder to Shareholders regarding Unclaimed Dividends and Transfer to IEPF
  • General1 Jun 2026
    Intimation Of Effective Date For The Scheme Of Demerger Involving Arco Lab Private Limited ('Arco Lab') And Pivot Path Private Limited ('Pivot Path')
    Intimation of Effective Date for Scheme of Demerger involving Arco Lab Private Limited ("Arco Lab") and ("Pivot Path Private Limited").
  • Analyst / Investor Meet28 May 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Schedule of Analyst/ Institutional Investor''s Meeting - as enclosed.
  • Analyst / Investor Meet28 May 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Schedule of Analyst/ Institutional Investor''s Meet - as enclosed.
  • Analyst / Investor Meet28 May 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Schedule of Analyst/ Institutional Investor''s meet - as enclosed
  • Analyst / Investor Meet28 May 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Schedule of Analyst/ Institutional Investor''s Meet - As enclosed.
  • Analyst / Investor Meet28 May 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Schedule of Analyst/ Institutional Investor''s Meet - as enclosed.
  • General20 May 2026
    Completion Of US-FDA Inspection At The Company'S Flagship Facility In Bangalore
    Completion of US-FDA Inspection at the Company''s flagship facility in Bangalore
  • Change in Directorate20 May 2026
    Announcement under Regulation 30 (LODR)-Change in Directorate
    Update with regard to our intimation dated May 18, 2026
  • General20 May 2026
    Pronouncement Of Order By The Hon'Ble NCLT, Bengaluru Bench Regarding Scheme Of Arrangement For Demerger Of Demerged Undertaking Of Arco Lab Private Limited, A Wholly Owned Subsidiary Of Strides Pharma Science Limited.
    Pronouncement of Order by NCLT Bengaluru Bench regarding Scheme of Arrangement for Demerger of Demerged Undertaking of Arco Lab Private Limited, a wholly owned Subsidiary of Strides Pharma ....
  • Newspaper Publication19 May 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper Advertisement - Audited Financial Results for the quarter and financial year ended March 31, 2026
  • Analyst / Investor Meet18 May 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
    Audio Recording of Earnings Call pertaining to the audited Financial Results for the quarter and financial year ended March 31, 2026
  • Change in Management18 May 2026
    Announcement under Regulation 30 (LODR)-Change in Management
    Update with regard to our intimation dated May 18, 2026 regarding movement in Board of Directors, KMP and SMP of the Company
  • Outcome of Board Meeting18 May 2026
    Board Meeting Outcome for Outcome Of Board Meeting Held On May 18, 2026
    Outcome of Board Meeting held on May 18, 2026
  • Change in Management18 May 2026
    Announcement under Regulation 30 (LODR)-Change in Management
    Identification of Senior Management Personnel

Frequently Asked Questions

Where can I download the annual report of Strides Pharma Science Ltd.?
Annual reports of Strides Pharma Science Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Strides Pharma Science Ltd.?
Quarterly earnings results and presentations of Strides Pharma Science Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Strides Pharma Science Ltd. publish earnings call transcripts?
Earnings call transcripts of Strides Pharma Science Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Strides Pharma Science Ltd.?
Investor presentations and annual day presentations of Strides Pharma Science Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Strides Pharma Science Ltd.?
Corporate announcements and regulatory filings of Strides Pharma Science Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Strides Pharma Science Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Strides Pharma Science Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Strides Pharma Science Ltd.?
The ISIN (International Securities Identification Number) of Strides Pharma Science Ltd. is INE939A01011. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Strides Pharma Science Ltd. listed?
Strides Pharma Science Ltd. is listed on NSE and BSE. The NSE symbol is STAR and the BSE code is -.
Where can I find the shareholding pattern of Strides Pharma Science Ltd.?
The quarterly shareholding pattern of Strides Pharma Science Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Strides Pharma Science Ltd. on Sharpely?
Share price data for Strides Pharma Science Ltd. is updated as of 3 Jul 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.